Rainbow Childrens Medicare Limited has informed the Exchange regarding Appointment of M/s. Lavanya & Associates LLP, KVN Lavanya, Partner as the Cost Auditors of the company for FY 2026-27.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare Limited held its Board meeting on May 23, 2026, approving several key matters. The statutory auditors S.R. Batliboi & Associates LLP gave an unmodified (clean) opinion on the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026. The Board recommended a final dividend of ₹3.5 per equity share (35% on face value of ₹10) for FY 2025-26, payable after shareholder approval at the 28th AGM scheduled for July 29, 2026 (Record Date: July 21, 2026). Key director re-appointments were approved: Dr. Ramesh Kancharla as Chairman & Managing Director and Dr. Dinesh Kumar Chirla as Whole Time Director, both for 5-year terms from August 2026. Independent Directors Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati were also re-appointed for second 5-year terms. Additionally, M/s. Lavanya & Associates LLP was re-appointed as Cost Auditors for FY 2026-27.
The clean audit opinion signals financial health and transparency, while the dividend recommendation and continued leadership stability are positive signals for shareholders. The company appears to be operating normally with no red flags in governance or financial reporting.